Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-035282
Filing Date
2026-03-27
Accepted
2026-03-27 11:38:07
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5988
  Complete submission text file 0001213900-26-035282.txt   7585
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Issuer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 329 11TH ST CRESSKILL NJ 07626
Business Address
Lankry Shai S (Reporting) CIK: 0002124455 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37643 | Film No.: 26803247